April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Long-Term Survival of Corneal Allografts after Penetrating Keratoplasty and Autologous Cultivated Limbal Epithelial Transplantation
Author Affiliations & Notes
  • Virender S. Sangwan
    Cornea & Ocular Immunology, LV Prasad Eye Institute, Hyderabad, India
  • Sayan Basu
    Cornea & Ocular Immunology, LV Prasad Eye Institute, Hyderabad, India
  • Ashik Mohamed
    Cornea & Ocular Immunology, LV Prasad Eye Institute, Hyderabad, India
  • Sunita Chaurasia
    Cornea & Ocular Immunology, LV Prasad Eye Institute, Hyderabad, India
  • Kunjal Sejpal
    Cornea & Ocular Immunology, LV Prasad Eye Institute, Hyderabad, India
  • Footnotes
    Commercial Relationships  Virender S. Sangwan, None; Sayan Basu, None; Ashik Mohamed, None; Sunita Chaurasia, None; Kunjal Sejpal, None
  • Footnotes
    Support  Department of Biotechnology, India (BT/01/COE/06/02/10), partnership grant from the Champalimaud Foundation, Portugal
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 362. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Virender S. Sangwan, Sayan Basu, Ashik Mohamed, Sunita Chaurasia, Kunjal Sejpal; Long-Term Survival of Corneal Allografts after Penetrating Keratoplasty and Autologous Cultivated Limbal Epithelial Transplantation. Invest. Ophthalmol. Vis. Sci. 2011;52(14):362.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

This study aims to report the long-term survival of corneal allografts in eyes undergoing autologus cultivated limbal epithelial transplantation (CLET) and penetrating keratoplasty (PK).

 
Methods:
 

This was a retrospective interventional case series that included 43 eyes of 43 patients with unilateral limbal stem cell deficiency (LSCD) due to ocular burns; 10 eyes underwent simultaneous (single-stage) and 33 eyes underwent consecutive (two-stage with minimum interval of 6 weeks) autologous CLET and PK. The medical record of each patient was reviewed for demographics, primary etiology, previous surgical procedures, preoperative and postoperative best corrected visual acuity (BCVA), clinical findings and complications. The primary outcome measure was corneal allograft failure, defined clinically as irreversible loss of central graft clarity. The survival of the corneal allograft was estimated using Kaplan Meier survival analysis. Risk factors of graft failure were analyzed using Cox proportional hazards model. The secondary outcome measures were post-operative best corrected visual acuity (BCVA) and complications.

 
Results:
 

Most patients were young (median age: 18 years) males (76%) with LSCD due to alkali burns (79%) and a mean follow-up of 4.38 ± 1.84 (range 1 to 8) years. The overall corneal allograft survival was 55.81 ± 7.57% at 1 year (median survival of 2.5 years); the corneal allograft survival after two-stage CLET and PK was 66.67 ± 8.13% at 1 year (median survival of 3.3 years). Single-stage CLET and PK had a greater risk of both corneal allograft failure (hazards ratio 4.5, P=0.006) and recurrence of LSCD (60%, P= 0.02), as compared to two-stage surgery. Failure occurred in 25 eyes due to graft rejection (36%), graft infiltrate (28%), recurrence of LSCD (8%) or combination of causes (28%). One third of the eyes achieved a BCVA of 20/60 or better. The commonest cause for low vision in spite of a clear graft was amblyopia.

 
Conclusions:
 

The risk of corneal allograft failure in these eyes is high and survival decreases with time; avoiding simultaneous limbal and corneal transplantation and adopting measures to prevent the causes of corneal allograft failure are needed to improve outcomes.

 
Keywords: transplantation • cornea: clinical science 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×